We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Expert: In Clearing Path for Lemtrada, Genzyme Skirts Marketing Slip
Expert: In Clearing Path for Lemtrada, Genzyme Skirts Marketing Slip
August 24, 2012
Apparently assured of U.S. and EU approval for Lemtrada in relapsing multiple sclerosis (MS), Genzyme is pulling its leukemia drug Campath, which has the same active ingredient, so Lemtrada can better compete in the MS space.